TY - JOUR
T1 - Impaired glucose disposal following mild hypoglycemia in nondiabetic and type I diabetic humans
AU - Davis, Maris R.
AU - Shamoon, Harry
N1 - Funding Information:
From the Department of Medicine, Division of Endocrinology and the Diabetes Research and Training Center, Albert Einstein College of Medicine, New York NY. Supported m part by National Institutes of Health Grants No. ROl-DK36617 and DK 20541, and by a Fellowship Grant from the Juvenile Diabetes Foundation International. Presented in part at the 50th annual meeting of the American Diabetes Association, Atlanta, GA, June 17-19, 1991. Address reprint request to Harry Shamoon, MD, Department of Medicine, Division of Endocrinology and the Diabetes Research and Training Center, Albert Einstein College of Medicine, 1300 Mom’s Park Ave, Bronx, NY 10461. Copyright 0 I992 by W.B. Saunders Company 0026-0495/9214102-0022$03.OOiO
PY - 1992/2
Y1 - 1992/2
N2 - Insulin-mediated glucose disposal was studied immediately prior to and following moderate hypoglycemia in nondiabetic subjects and subjects with insulin-dependent (type I) diabetes mellitus (IDDM), the latter having varying epinephrine secretory capacities. Plasma insulin concentration was fixed throughout the study at ∼300 to 400 pmol/L to avoid effects of waning insulin action and plasma glucose was clamped at either 5 mmol/L (euglycemic control) or at 3.1 mmol/L (hypoglycemic) periods of 120 minutes. Baseline (clamp 1) and postexperiment (clamp 2) periods were assessed for net glucose disposal (as a function of the exogenous glucose infusion rate) and glucose kinetics using 3H-glucose. In normal subjects, glucose disposal increased progressively by 132% during control studies but only by 57% with intervening hypoglycemia (P < .005). Similarly, subjects with IDDM displayed marked reduction in glucose disposal following hypoglycemia (152% increment during control v 33% during hypoglycemia, P < .025). These changes were mediated by reduction of whole-body glucose uptake (rate of glucose disappearance [Rd], [3H]-3-glucose) and metabolic clearance rates with comparable suppression of hepatic glucose production in both groups. The increase in plasma free-fatty acids (FFA) following hypoglycemia was modest but greater in subjects with IDDM (P < .01), whereas IDDM had reduced concentrations of epinephrine (P < .01) and glucagon (P < .005) during hypoglycemia. In subjects with IDDM but not in normal subjects, the change in posthypoglycemia glucose disposal was inversely correlated with the increase in plasma norepinephrine (R2 = .54, P < .004) and epinephrine (R2 = .32, P < .04). Glucose disposal did not correlate with other counterregulatory hormones, plasma FFA, or antecedent glycemic control. The data suggest that posthypoglycemic insulin resistance develops immediately following mild hypoglycemia in humans. Impaired glucose disposal occurs in IDDM despite reduced epinephrine secretory responses and correlates with parameters of neuroadrenergic function.
AB - Insulin-mediated glucose disposal was studied immediately prior to and following moderate hypoglycemia in nondiabetic subjects and subjects with insulin-dependent (type I) diabetes mellitus (IDDM), the latter having varying epinephrine secretory capacities. Plasma insulin concentration was fixed throughout the study at ∼300 to 400 pmol/L to avoid effects of waning insulin action and plasma glucose was clamped at either 5 mmol/L (euglycemic control) or at 3.1 mmol/L (hypoglycemic) periods of 120 minutes. Baseline (clamp 1) and postexperiment (clamp 2) periods were assessed for net glucose disposal (as a function of the exogenous glucose infusion rate) and glucose kinetics using 3H-glucose. In normal subjects, glucose disposal increased progressively by 132% during control studies but only by 57% with intervening hypoglycemia (P < .005). Similarly, subjects with IDDM displayed marked reduction in glucose disposal following hypoglycemia (152% increment during control v 33% during hypoglycemia, P < .025). These changes were mediated by reduction of whole-body glucose uptake (rate of glucose disappearance [Rd], [3H]-3-glucose) and metabolic clearance rates with comparable suppression of hepatic glucose production in both groups. The increase in plasma free-fatty acids (FFA) following hypoglycemia was modest but greater in subjects with IDDM (P < .01), whereas IDDM had reduced concentrations of epinephrine (P < .01) and glucagon (P < .005) during hypoglycemia. In subjects with IDDM but not in normal subjects, the change in posthypoglycemia glucose disposal was inversely correlated with the increase in plasma norepinephrine (R2 = .54, P < .004) and epinephrine (R2 = .32, P < .04). Glucose disposal did not correlate with other counterregulatory hormones, plasma FFA, or antecedent glycemic control. The data suggest that posthypoglycemic insulin resistance develops immediately following mild hypoglycemia in humans. Impaired glucose disposal occurs in IDDM despite reduced epinephrine secretory responses and correlates with parameters of neuroadrenergic function.
UR - http://www.scopus.com/inward/record.url?scp=0026575213&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026575213&partnerID=8YFLogxK
U2 - 10.1016/0026-0495(92)90156-5
DO - 10.1016/0026-0495(92)90156-5
M3 - Article
C2 - 1736045
AN - SCOPUS:0026575213
SN - 0026-0495
VL - 41
SP - 216
EP - 223
JO - Metabolism
JF - Metabolism
IS - 2
ER -
